Filing Details
- Accession Number:
- 0001493152-20-000167
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-03 19:45:27
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-03 19:45:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1393434 | Ocular Therapeutix Inc | OCUL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595855 | Opaleye Management Inc. | One Boston Place, 26Th Floor Boston MA 02108 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.0001 Per Share | Acquisiton | 2020-01-02 | 15,000 | $3.90 | 4,918,500 | No | 4 | P | Indirect | By Opaleye, L.P. |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | By Opaleye, L.P. |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $3.9005. The range of purchase prices on the transaction date was $3.895 to $3.94 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
- Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
Billionaire Hedge Funds
